Adicet Bio Inc. Company Profile
NASDAQ: ACETHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Adicet Bio at a glance
Adicet Bio Inc. (NASDAQ: ACET) is a Biotechnology company in the Healthcare sector headquartered in Boston, MA. Adicet Bio is led by Mr. Chen Schor BA, CPA, M.B.A. and employs about 102 people. The company's shares have traded publicly since 2018.
At a market capitalization of $53.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001720580, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Adicet Bio do?
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Adicet Bio Inc.
- Ticker
- NASDAQ: ACET
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Chen Schor BA, CPA, M.B.A.
- Employees
- 102
- Headquarters
- 131 Dartmouth Street, Boston, MA, United States
- Phone
- 650 503 9095
- Website
- adicetbio.com
- IPO year
- 2018
- Market cap
- $53.73M
- SEC CIK
- 0001720580
Companies similar to Adicet Bio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LONALeonaBio Inc. | 5.75 | -1.37% | $54.17M | vs ACET |
| CNTBConnect Biopharma Holdings Limited | 0.8807 | -6.77% | $55.46M | vs ACET |
| CRBUCaribou Biosciences Inc. | 0.4812 | -22.06% | $51.59M | vs ACET |
| ATHEAlterity Therapeutics Limited ADR | 3.07 | -7.53% | $55.90M | vs ACET |
| GUTSFractyl Health Inc. | 4.23 | -6.42% | $56.11M | vs ACET |
| INKTMiNK Therapeutics Inc. | 11.00 | -3.68% | $56.13M | vs ACET |
| HYPDHyperion DeFi Inc. | 3.37 | -6.27% | $51.16M | vs ACET |
| SERSerina Therapeutics Inc. | 2.01 | 0.00% | $51.05M | vs ACET |